Back
Keros Therapeutics, Inc. Stock Price Chart
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now
Buy
60
KROS
Keros Therapeutics, Inc.
Last Price:
$21.28
Seasonality Move:
6.31%
7 Day Trial
ALL ACCESS PASS
$
7
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Keros Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.3 | Buy |
| 20-day SMA: | 17.58 | Buy |
| 50-day SMA: | 16.25 | Buy |
| 200-day SMA: | 14.25 | Buy |
| 8-day EMA: | 18.83 | Buy |
| 20-day EMA: | 17.7 | Buy |
| 50-day EMA: | 16.63 | Buy |
| 200-day EMA: | 18.4 | Buy |
Keros Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.93 | Buy |
| Relative Strength Index (14 RSI): | 80.46 | Buy |
| Chaikin Money Flow: | 794624 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.81 - 18.53) | Buy |
| Bollinger Bands (100): | (14.24 - 16.88) | Buy |
Keros Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Keros Therapeutics, Inc. Stock
Is Keros Therapeutics, Inc. Stock a Buy?
-
Keros Therapeutics, Inc. share price is 21.69 while KROS 8-day simple moving average is 18.30, which is a Buy signal.
-
The stock price of KROS is 21.69 while Keros Therapeutics, Inc. 20-day SMA is 17.58, which makes it a Buy.
-
Keros Therapeutics, Inc. 50-day simple moving average is 16.25 while KROS share price is 21.69, making it a Buy technically.
-
KROS stock price is 21.69 and Keros Therapeutics, Inc. 200-day simple moving average is 14.25, creating a Buy signal.
KROS Technical Analysis vs Fundamental Analysis
Buy
60
Keros Therapeutics, Inc. (KROS)
is a Buy
Is Keros Therapeutics, Inc. a Buy or a Sell?
-
Keros Therapeutics, Inc. stock is rated a BuyThe current Keros Therapeutics, Inc. [KROS] share price is $21.69. The Score for KROS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Keros Therapeutics, Inc. Stock Info
Market Cap:
660.8M
Price in USD:
21.69
Share Volume:
1.1M
Keros Therapeutics, Inc. 52-Week Range
52-Week High:
72.37
52-Week Low:
9.12
Buy
60
Keros Therapeutics, Inc. (KROS)
is a Buy
Keros Therapeutics, Inc. Share Price Forecast
-
What is the Keros Therapeutics, Inc. stock price today?The Keros Therapeutics, Inc. stock price is 21.69 USD today.
-
Will KROS stock go up or go down?Keros Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Keros Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Keros Therapeutics, Inc. is not overvalued.
Is Keros Therapeutics, Inc. Stock a Buy?
-
Keros Therapeutics, Inc. share price is 21.69 while KROS 8-day exponential moving average is 18.83, which is a Buy signal.
-
The stock price of KROS is 21.69 while Keros Therapeutics, Inc. 20-day EMA is 17.70, which makes it a Buy.
-
Keros Therapeutics, Inc. 50-day exponential moving average is 16.63 while KROS share price is 21.69, making it a Buy technically.
-
KROS stock price is 21.69 and Keros Therapeutics, Inc. 200-day simple moving average is 18.40, creating a Buy signal.
Fundamental Analysis of Keros Therapeutics, Inc.
Is Keros Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.22 per share.
Technical Analysis of Keros Therapeutics, Inc.
Should I short Keros Therapeutics, Inc. stock?
-
KROS Moving Average Covergence Divergence (MACD) indicator is 0.93, suggesting Keros Therapeutics, Inc. is a Buy
-
Keros Therapeutics, Inc. Relative Strength Index (RSI) is 80.46, which suggest Keros Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Keros Therapeutics, Inc. is (15.81 - 18.53), which suggest Keros Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Keros Therapeutics, Inc. is (14.24 - 16.88), which suggest Keros Therapeutics, Inc. is a Buy
* Keros Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.